33 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
JNJ multiple myeloma therapy outperforms standard of care by 58% https://seekingalpha.com/news/4045689-jnj-multiple-myeloma-therapy-outperforms-standard-of-care?source=feed_sector_healthcare Dec 12, 2023 - Johnson & Johnson's (JNJ) multiple myeloma therapy Darzalex Faspro in combination with traditional treatments outperforms standard of care. Read more here.
JNJ looking to move talc powder unit to Texas ahead of bankruptcy filing: report https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?source=feed_sector_healthcare Jan 22, 2024 - Johnson & Johnson (JNJ) is reportedly looking to relocate its LTL talc powder unit to Texas ahead of an expected third bankruptcy filing for the subsidiary. Read more here.
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/01/23/johnson-johnson-jnj-q4-2023-earnings-call-transcri/?source=iedfolrf0000001 Jan 23, 2024 - JNJ earnings call for the period ending December 31, 2023.
7 Dividend Stocks That Pay Me More Than $500 Per Month https://www.fool.com/investing/2024/02/03/7-dividend-stocks-that-pay-me-more-than-500-per-mo/?source=iedfolrf0000001 Feb 03, 2024 - These stocks pay safe, reliable, and growing dividends.
Can JNJ reverse loss in 2024 on EPS growth, eyes on talc litigation https://seekingalpha.com/news/4050710-can-jnj-reverse-loss-in-2024-on-eps-growth-eyes-on-talc-litigation?source=feed_sector_healthcare Dec 27, 2023 - Johnson & Johnson 2024: What to Expect Wells Fargo downgraded Johnson & Johnson (JNJ) to equal weight and lowered PT to $163 from $170 as analyst expects EPS gr
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024 https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/?source=iedfolrf0000001 Dec 29, 2023 - There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.
2 Best Warren Buffett Stocks to Buy for the Long Haul https://www.fool.com/investing/2023/12/30/2-best-warren-buffett-stocks-to-buy-for-the-long/?source=iedfolrf0000001 Dec 30, 2023 - These companies need no introduction.
3 Unstoppable Dividend Stocks That Could Pay You for Life https://www.fool.com/investing/2024/02/17/3-unstoppable-dividend-stocks-that-could-pay-you-f/?source=iedfolrf0000001 Feb 17, 2024 - There are no certainties in life or on the stock market. These companies' dividends are about as close as we can get.
Meet the "Magnificent Seven" Stock That Pays More Dividends Than Any Other U.S.-Based Company https://www.fool.com/investing/2024/03/16/magnificent-seven-stock-pays-most-dividends/?source=iedfolrf0000001 Mar 16, 2024 - Microsoft is the complete package.
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca https://www.zacks.com/stock/news/2193151/lilly-lly-gets-second-fda-nod-for-lymphoma-drug-jaypirca?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193151 Dec 04, 2023 - Following the latest approval, Lilly's (LLY) Jaypirca is the first and the only non-covalent BTK inhibitor to extend the benefit of targeting the BTK pathway.

Pages: 1234

Page 1>